IBDEI340 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49661,1,3,0)
;;=3^Dementia w/o Bhv Dstrb,Unsp
;;^UTILITY(U,$J,358.3,49661,1,4,0)
;;=4^F03.90
;;^UTILITY(U,$J,358.3,49661,2)
;;=^5003050
;;^UTILITY(U,$J,358.3,49662,0)
;;=F01.51^^191^2477^30
;;^UTILITY(U,$J,358.3,49662,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49662,1,3,0)
;;=3^Vascular Dementia w/ Bhv Dstrb
;;^UTILITY(U,$J,358.3,49662,1,4,0)
;;=4^F01.51
;;^UTILITY(U,$J,358.3,49662,2)
;;=^5003047
;;^UTILITY(U,$J,358.3,49663,0)
;;=F01.50^^191^2477^31
;;^UTILITY(U,$J,358.3,49663,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49663,1,3,0)
;;=3^Vascular Dementia w/o Bhv Dstrb
;;^UTILITY(U,$J,358.3,49663,1,4,0)
;;=4^F01.50
;;^UTILITY(U,$J,358.3,49663,2)
;;=^5003046
;;^UTILITY(U,$J,358.3,49664,0)
;;=A81.9^^191^2477^6
;;^UTILITY(U,$J,358.3,49664,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49664,1,3,0)
;;=3^Atypical Virus Infection of CNS,Unspec
;;^UTILITY(U,$J,358.3,49664,1,4,0)
;;=4^A81.9
;;^UTILITY(U,$J,358.3,49664,2)
;;=^5000414
;;^UTILITY(U,$J,358.3,49665,0)
;;=A81.09^^191^2477^8
;;^UTILITY(U,$J,358.3,49665,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49665,1,3,0)
;;=3^Creutzfeldt-Jakob Disease NEC
;;^UTILITY(U,$J,358.3,49665,1,4,0)
;;=4^A81.09
;;^UTILITY(U,$J,358.3,49665,2)
;;=^5000410
;;^UTILITY(U,$J,358.3,49666,0)
;;=A81.00^^191^2477^9
;;^UTILITY(U,$J,358.3,49666,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49666,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Unspec
;;^UTILITY(U,$J,358.3,49666,1,4,0)
;;=4^A81.00
;;^UTILITY(U,$J,358.3,49666,2)
;;=^5000409
;;^UTILITY(U,$J,358.3,49667,0)
;;=A81.01^^191^2477^10
;;^UTILITY(U,$J,358.3,49667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49667,1,3,0)
;;=3^Creutzfeldt-Jakob Disease,Variant
;;^UTILITY(U,$J,358.3,49667,1,4,0)
;;=4^A81.01
;;^UTILITY(U,$J,358.3,49667,2)
;;=^336701
;;^UTILITY(U,$J,358.3,49668,0)
;;=A81.89^^191^2477^7
;;^UTILITY(U,$J,358.3,49668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49668,1,3,0)
;;=3^Atypical Virus Infections of CNS NEC
;;^UTILITY(U,$J,358.3,49668,1,4,0)
;;=4^A81.89
;;^UTILITY(U,$J,358.3,49668,2)
;;=^5000413
;;^UTILITY(U,$J,358.3,49669,0)
;;=A81.2^^191^2477^27
;;^UTILITY(U,$J,358.3,49669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49669,1,3,0)
;;=3^Progressive Multifocal Leukoencephalopathy
;;^UTILITY(U,$J,358.3,49669,1,4,0)
;;=4^A81.2
;;^UTILITY(U,$J,358.3,49669,2)
;;=^5000411
;;^UTILITY(U,$J,358.3,49670,0)
;;=B20.^^191^2477^17
;;^UTILITY(U,$J,358.3,49670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49670,1,3,0)
;;=3^HIV Disease w/ Dementia w/ Bhv Dstrb
;;^UTILITY(U,$J,358.3,49670,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,49670,2)
;;=^5000555^F02.81
;;^UTILITY(U,$J,358.3,49671,0)
;;=B20.^^191^2477^18
;;^UTILITY(U,$J,358.3,49671,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49671,1,3,0)
;;=3^HIV Disease w/ Dementia w/o Bhv Dstrb
;;^UTILITY(U,$J,358.3,49671,1,4,0)
;;=4^B20.
;;^UTILITY(U,$J,358.3,49671,2)
;;=^5000555^F02.80
;;^UTILITY(U,$J,358.3,49672,0)
;;=F10.27^^191^2477^1
;;^UTILITY(U,$J,358.3,49672,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49672,1,3,0)
;;=3^Alc Dep w/ Alc-Induced Persist Dementia
;;^UTILITY(U,$J,358.3,49672,1,4,0)
;;=4^F10.27
;;^UTILITY(U,$J,358.3,49672,2)
;;=^5003095
;;^UTILITY(U,$J,358.3,49673,0)
;;=F19.97^^191^2477^29
;;^UTILITY(U,$J,358.3,49673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49673,1,3,0)
;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI340 3820 printed Sep 23, 2025@20:17:23 Page 2
IBDEI340 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49661,1,3,0)
+2 ;;=3^Dementia w/o Bhv Dstrb,Unsp
+3 ;;^UTILITY(U,$J,358.3,49661,1,4,0)
+4 ;;=4^F03.90
+5 ;;^UTILITY(U,$J,358.3,49661,2)
+6 ;;=^5003050
+7 ;;^UTILITY(U,$J,358.3,49662,0)
+8 ;;=F01.51^^191^2477^30
+9 ;;^UTILITY(U,$J,358.3,49662,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,49662,1,3,0)
+12 ;;=3^Vascular Dementia w/ Bhv Dstrb
+13 ;;^UTILITY(U,$J,358.3,49662,1,4,0)
+14 ;;=4^F01.51
+15 ;;^UTILITY(U,$J,358.3,49662,2)
+16 ;;=^5003047
+17 ;;^UTILITY(U,$J,358.3,49663,0)
+18 ;;=F01.50^^191^2477^31
+19 ;;^UTILITY(U,$J,358.3,49663,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,49663,1,3,0)
+22 ;;=3^Vascular Dementia w/o Bhv Dstrb
+23 ;;^UTILITY(U,$J,358.3,49663,1,4,0)
+24 ;;=4^F01.50
+25 ;;^UTILITY(U,$J,358.3,49663,2)
+26 ;;=^5003046
+27 ;;^UTILITY(U,$J,358.3,49664,0)
+28 ;;=A81.9^^191^2477^6
+29 ;;^UTILITY(U,$J,358.3,49664,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,49664,1,3,0)
+32 ;;=3^Atypical Virus Infection of CNS,Unspec
+33 ;;^UTILITY(U,$J,358.3,49664,1,4,0)
+34 ;;=4^A81.9
+35 ;;^UTILITY(U,$J,358.3,49664,2)
+36 ;;=^5000414
+37 ;;^UTILITY(U,$J,358.3,49665,0)
+38 ;;=A81.09^^191^2477^8
+39 ;;^UTILITY(U,$J,358.3,49665,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,49665,1,3,0)
+42 ;;=3^Creutzfeldt-Jakob Disease NEC
+43 ;;^UTILITY(U,$J,358.3,49665,1,4,0)
+44 ;;=4^A81.09
+45 ;;^UTILITY(U,$J,358.3,49665,2)
+46 ;;=^5000410
+47 ;;^UTILITY(U,$J,358.3,49666,0)
+48 ;;=A81.00^^191^2477^9
+49 ;;^UTILITY(U,$J,358.3,49666,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,49666,1,3,0)
+52 ;;=3^Creutzfeldt-Jakob Disease,Unspec
+53 ;;^UTILITY(U,$J,358.3,49666,1,4,0)
+54 ;;=4^A81.00
+55 ;;^UTILITY(U,$J,358.3,49666,2)
+56 ;;=^5000409
+57 ;;^UTILITY(U,$J,358.3,49667,0)
+58 ;;=A81.01^^191^2477^10
+59 ;;^UTILITY(U,$J,358.3,49667,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,49667,1,3,0)
+62 ;;=3^Creutzfeldt-Jakob Disease,Variant
+63 ;;^UTILITY(U,$J,358.3,49667,1,4,0)
+64 ;;=4^A81.01
+65 ;;^UTILITY(U,$J,358.3,49667,2)
+66 ;;=^336701
+67 ;;^UTILITY(U,$J,358.3,49668,0)
+68 ;;=A81.89^^191^2477^7
+69 ;;^UTILITY(U,$J,358.3,49668,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,49668,1,3,0)
+72 ;;=3^Atypical Virus Infections of CNS NEC
+73 ;;^UTILITY(U,$J,358.3,49668,1,4,0)
+74 ;;=4^A81.89
+75 ;;^UTILITY(U,$J,358.3,49668,2)
+76 ;;=^5000413
+77 ;;^UTILITY(U,$J,358.3,49669,0)
+78 ;;=A81.2^^191^2477^27
+79 ;;^UTILITY(U,$J,358.3,49669,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,49669,1,3,0)
+82 ;;=3^Progressive Multifocal Leukoencephalopathy
+83 ;;^UTILITY(U,$J,358.3,49669,1,4,0)
+84 ;;=4^A81.2
+85 ;;^UTILITY(U,$J,358.3,49669,2)
+86 ;;=^5000411
+87 ;;^UTILITY(U,$J,358.3,49670,0)
+88 ;;=B20.^^191^2477^17
+89 ;;^UTILITY(U,$J,358.3,49670,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,49670,1,3,0)
+92 ;;=3^HIV Disease w/ Dementia w/ Bhv Dstrb
+93 ;;^UTILITY(U,$J,358.3,49670,1,4,0)
+94 ;;=4^B20.
+95 ;;^UTILITY(U,$J,358.3,49670,2)
+96 ;;=^5000555^F02.81
+97 ;;^UTILITY(U,$J,358.3,49671,0)
+98 ;;=B20.^^191^2477^18
+99 ;;^UTILITY(U,$J,358.3,49671,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,49671,1,3,0)
+102 ;;=3^HIV Disease w/ Dementia w/o Bhv Dstrb
+103 ;;^UTILITY(U,$J,358.3,49671,1,4,0)
+104 ;;=4^B20.
+105 ;;^UTILITY(U,$J,358.3,49671,2)
+106 ;;=^5000555^F02.80
+107 ;;^UTILITY(U,$J,358.3,49672,0)
+108 ;;=F10.27^^191^2477^1
+109 ;;^UTILITY(U,$J,358.3,49672,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,49672,1,3,0)
+112 ;;=3^Alc Dep w/ Alc-Induced Persist Dementia
+113 ;;^UTILITY(U,$J,358.3,49672,1,4,0)
+114 ;;=4^F10.27
+115 ;;^UTILITY(U,$J,358.3,49672,2)
+116 ;;=^5003095
+117 ;;^UTILITY(U,$J,358.3,49673,0)
+118 ;;=F19.97^^191^2477^29
+119 ;;^UTILITY(U,$J,358.3,49673,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,49673,1,3,0)
+122 ;;=3^Psychoactive Substance Use w/ Persisting Dementia NEC
